Related Experiment Video
Updated: May 30, 2025

Hyperinsulinemic-Euglycemic Clamp in the Conscious Rat
Published on: February 7, 2011
Subtypes of Insulin Restriction in Diabetes Management: A Systematic Review
Aislinn B Beam1, Deborah J Wiebe2
1Department of Psychological Sciences, University of California, Merced, CA, USA. abeam@ucmerced.edu.
Purpose Of Review:
Insulin restriction is commonly studied as a form of disordered eating, but people may restrict insulin for many reasons. This systematic review examined how insulin restriction has been conceptualized and measured, and its associated predictors and outcomes.
Recent Findings:
Forty-seven unique articles measured non-specified insulin restriction (IR), insulin restriction specifically for weight control (IRWC), or both. Eight studies used non-specified measures to examine insulin restriction for a specific purpose. IR was more prevalent than IRWC, but both occurred equally among men and women across ages. Higher negative emotions were associated with both constructs, while lower self-management behaviors were examined and associated only with IR; both constructs were associated with higher HbA1c. When measured simultaneously, IR and IRWC were not correlated. There may be subtypes of insulin restriction. Future research should develop measures to assess and examine distinct subtypes, and translate findings into effective interventions for this dangerous behavior.
More Related Videos
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

